Procter & Gamble’s (PG) Hold Rating Reaffirmed at TD Cowen

Procter & Gamble (NYSE:PG)‘s stock had its “hold” rating restated by analysts at TD Cowen in a report released on Wednesday, Benzinga reports. They presently have a $150.00 price objective on the stock. TD Cowen’s price target points to a potential upside of 2.85% from the stock’s current price.

Several other research firms also recently weighed in on PG. Bank of America decreased their price target on shares of Procter & Gamble from $170.00 to $166.00 and set a “buy” rating on the stock in a research note on Friday, July 10th. Jefferies Financial Group raised their price target on shares of Procter & Gamble from $177.00 to $179.00 and gave the stock a “buy” rating in a research note on Friday, June 26th. Royal Bank Of Canada reissued an “outperform” rating on shares of Procter & Gamble in a research note on Wednesday, August 19th. BMO Capital Markets raised their price target on shares of Procter & Gamble from $169.00 to $170.00 and gave the stock an “outperform” rating in a research note on Monday, June 29th. Finally, HSBC reissued a “hold” rating and issued a $149.00 price target (down from $182.00) on shares of Procter & Gamble in a research note on Thursday, July 30th. Thirteen investment analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $161.55.

Procter & Gamble Price Performance

PG traded up $0.93 during midday trading on Wednesday, hitting $145.84. 3,154,371 shares of the company traded hands, compared to its average volume of 9,647,990. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43. The company has a market capitalization of $338.75 billion, a price-to-earnings ratio of 22.02, a PEG ratio of 3.60 and a beta of 0.39. Procter & Gamble has a 52-week low of $137.62 and a 52-week high of $167.25. The business has a 50 day simple moving average of $145.73 and a two-hundred day simple moving average of $146.00.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Wednesday, July 29th. The company reported $1.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.02. The business had revenue of $21.20 billion for the quarter, compared to the consensus estimate of $21.38 billion. Procter & Gamble had a net margin of 18.44% and a return on equity of 31.36%. The company’s revenue was up 1.5% compared to the same quarter last year. During the same period last year, the firm posted $1.48 earnings per share. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, equities analysts forecast that Procter & Gamble will post 6.98 earnings per share for the current fiscal year.

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CAO Matthew Janzaruk sold 359 shares of Procter & Gamble stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $145.24, for a total transaction of $52,141.16. Following the completion of the sale, the chief accounting officer directly owned 1,271 shares in the company, valued at $184,600.04. This trade represents a 22.02% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, insider Susan Whaley sold 2,238 shares of Procter & Gamble stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $143.79, for a total transaction of $321,802.02. Following the sale, the insider owned 26,989 shares of the company’s stock, valued at approximately $3,880,748.31. This represents a 7.66% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 6,627 shares of company stock worth $953,417 over the last three months. Insiders own 0.23% of the company’s stock.

Institutional Investors Weigh In On Procter & Gamble

A number of institutional investors have recently made changes to their positions in the stock. Baxter Bros Inc. purchased a new position in shares of Procter & Gamble during the 2nd quarter worth about $12,381,000. Empowered Funds LLC purchased a new position in shares of Procter & Gamble during the 2nd quarter worth about $53,549,000. Cibc World Market Inc. lifted its holdings in shares of Procter & Gamble by 40.6% during the 4th quarter. Cibc World Market Inc. now owns 511,833 shares of the company’s stock worth $73,351,000 after acquiring an additional 147,701 shares during the period. Resources Management Corp CT ADV lifted its holdings in shares of Procter & Gamble by 41.8% during the 4th quarter. Resources Management Corp CT ADV now owns 81,511 shares of the company’s stock worth $11,681,000 after acquiring an additional 24,010 shares during the period. Finally, Rokos Capital Management LLP purchased a new position in shares of Procter & Gamble during the 1st quarter worth about $29,914,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

About Procter & Gamble

The Procter & Gamble Company (NYSE: PG) is a consumer products company that develops, manufactures and markets branded products used in households and personal care routines. Its portfolio includes products in categories such as beauty, grooming, health care, fabric and home care, and family care.

Major brands associated with Procter & Gamble include Pampers, Tide, Gillette, Head & Shoulders, Pantene, Oral-B, Crest, Olay, Old Spice, Febreze, Mr. Clean, Swiffer and Bounty. The company sells its products through retailers, e-commerce platforms and other distribution channels.

Founded in Cincinnati, Ohio, in 1837 by William Procter and James Gamble, the company has grown into a global consumer goods business serving customers in markets around the world.